ARCHIVES

FDA Approves Ribavirin Phase 102 Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

M.D. Anderson, Madrid In Joint Program

September 2, 1988

ACS announces 415 New Awards

August 31, 1979

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG

November 3, 1978

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996